| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 106.110 | 99.510 | 142.677 | 75.638 | 74.716 | 71.913 | 67.176 | 59.173 | 70.854 | 68.146 |
| Total Income - EUR | 107.697 | 100.139 | 142.711 | 75.662 | 75.374 | 71.976 | 67.180 | 59.249 | 70.893 | 68.301 |
| Total Expenses - EUR | 91.521 | 87.659 | 81.433 | 26.790 | 49.936 | 26.546 | 87.392 | 23.367 | 41.402 | 40.292 |
| Gross Profit/Loss - EUR | 16.176 | 12.480 | 61.278 | 48.872 | 25.439 | 45.429 | -20.213 | 35.882 | 29.491 | 28.009 |
| Net Profit/Loss - EUR | 13.361 | 10.338 | 59.851 | 48.116 | 24.692 | 43.272 | -22.027 | 34.196 | 28.868 | 27.008 |
| Employees | 3 | 0 | 4 | 3 | 3 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Biotech Energia Ro S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 754 | 0 | 0 | 0 | 1.727 | 1.428 | 1.170 | 906 | 641 |
| Current Assets | 450.299 | 482.722 | 552.244 | 259.770 | 303.717 | 323.806 | 296.617 | 343.000 | 366.583 | 394.706 |
| Inventories | 250.099 | 317.831 | 319.526 | 0 | 948 | 0 | 1.041 | 1.045 | 1.041 | 1.066 |
| Receivables | 133.267 | 60.594 | 69.165 | 49.063 | 301.852 | 253.937 | 256.880 | 270.392 | 256.891 | 254.925 |
| Cash | 66.933 | 104.297 | 163.553 | 210.707 | 917 | 69.869 | 38.696 | 71.563 | 108.651 | 138.715 |
| Shareholders Funds | 48.212 | 22.983 | 82.446 | 230.062 | 252.555 | 291.039 | 262.559 | 297.569 | 325.534 | 350.723 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 1.696 | 460.493 | 80.197 | 29.708 | 51.162 | 34.543 | 35.536 | 46.651 | 42.004 | 44.675 |
| Income in Advance | 400.391 | 396.308 | 389.602 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "3314 - 3314" | |||||||||
| CAEN Financial Year |
3314
|
|||||||||
Comments - Biotech Energia Ro S.r.l.